Azacitidine
- Product NDC
- 69097-368
- 11-digit product format
- 690970368
- Labeler code
- 69097
- Product ID
- 69097-368_2413bf0f-e9bf-441a-9389-229c5ae8fa40
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA209540
- Marketing category
- ANDA
- Marketing start
- 2018-05-04
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-368 | AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CIPLA USA INC.] | 9 | Legacy NDC | 20221115_ad4ac593-b811-4d5a-a336-edb98689f188.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-368-40 | 69097036840 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (69097-368-40) | 2018-05-04 | 0000-00-00 | No | No | Current |